| UniProt ID | TTP_HUMAN | |
|---|---|---|
| UniProt AC | P26651 | |
| Protein Name | mRNA decay activator protein ZFP36 {ECO:0000305} | |
| Gene Name | ZFP36 {ECO:0000312|HGNC:HGNC:12862} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 326 | |
| Subcellular Localization | Nucleus . Cytoplasm . Cytoplasmic granule . Cytoplasm, P-body . Shuttles between nucleus and cytoplasm in a CRM1-dependent manner (By similarity). Localized predominantly in the cytoplasm in a p38 MAPK- and YWHAB-dependent manner (By similarity). Col | |
| Protein Description | Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis. [PubMed: 9703499] | |
| Protein Sequence | MDLTAIYESLLSLSPDVPVPSDHGGTESSPGWGSSGPWSLSPSDSSPSGVTSRLPGRSTSLVEGRSCGWVPPPPGFAPLAPRLGPELSPSPTSPTATSTTPSRYKTELCRTFSESGRCRYGAKCQFAHGLGELRQANRHPKYKTELCHKFYLQGRCPYGSRCHFIHNPSEDLAAPGHPPVLRQSISFSGLPSGRRTSPPPPGLAGPSLSSSSFSPSSSPPPPGDLPLSPSAFSAAPGTPLARRDPTPVCCPSCRRATPISVWGPLGGLVRTPSVQSLGSDPDEYASSGSSLGGSDSPVFEAGVFAPPQPVAAPRRLPIFNRISVSE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | AIYESLLSLSPDVPV HHHHHHHCCCCCCCC | 31.90 | 16262601 | |
| 18 | Phosphorylation | LSLSPDVPVPSDHGG HCCCCCCCCCCCCCC | 39.42 | - | |
| 21 | Phosphorylation | SPDVPVPSDHGGTES CCCCCCCCCCCCCCC | 42.34 | 16262601 | |
| 27 | Phosphorylation | PSDHGGTESSPGWGS CCCCCCCCCCCCCCC | 53.12 | - | |
| 41 | Phosphorylation | SSGPWSLSPSDSSPS CCCCCCCCCCCCCCC | 19.49 | 16262601 | |
| 43 | Phosphorylation | GPWSLSPSDSSPSGV CCCCCCCCCCCCCCC | 46.91 | 16262601 | |
| 46 | Phosphorylation | SLSPSDSSPSGVTSR CCCCCCCCCCCCCCC | 28.24 | 16262601 | |
| 47 | Phosphorylation | LSPSDSSPSGVTSRL CCCCCCCCCCCCCCC | 38.77 | - | |
| 48 | Phosphorylation | SPSDSSPSGVTSRLP CCCCCCCCCCCCCCC | 48.09 | 16262601 | |
| 49 | Phosphorylation | PSDSSPSGVTSRLPG CCCCCCCCCCCCCCC | 30.06 | - | |
| 52 | Phosphorylation | SSPSGVTSRLPGRST CCCCCCCCCCCCCCC | 29.43 | 14688255 | |
| 54 | Phosphorylation | PSGVTSRLPGRSTSL CCCCCCCCCCCCCCE | 5.44 | - | |
| 58 | Phosphorylation | TSRLPGRSTSLVEGR CCCCCCCCCCEECCC | 28.41 | 26657352 | |
| 59 | Phosphorylation | SRLPGRSTSLVEGRS CCCCCCCCCEECCCC | 25.39 | 26699800 | |
| 60 | Phosphorylation | RLPGRSTSLVEGRSC CCCCCCCCEECCCCC | 31.50 | 23911959 | |
| 66 | Phosphorylation | TSLVEGRSCGWVPPP CCEECCCCCCCCCCC | 28.04 | 16262601 | |
| 72 | Phosphorylation | RSCGWVPPPPGFAPL CCCCCCCCCCCCCCC | 37.79 | 16262601 | |
| 82 | Methylation | GFAPLAPRLGPELSP CCCCCCCCCCCCCCC | 46.82 | 115384921 | |
| 88 | Methylation | PRLGPELSPSPTSPT CCCCCCCCCCCCCCC | 22.97 | - | |
| 88 | Phosphorylation | PRLGPELSPSPTSPT CCCCCCCCCCCCCCC | 22.97 | 28355574 | |
| 90 | Phosphorylation | LGPELSPSPTSPTAT CCCCCCCCCCCCCCC | 37.12 | 29255136 | |
| 92 | Phosphorylation | PELSPSPTSPTATST CCCCCCCCCCCCCCC | 52.23 | 29255136 | |
| 93 | Phosphorylation | ELSPSPTSPTATSTT CCCCCCCCCCCCCCC | 24.52 | 29255136 | |
| 94 | Phosphorylation | LSPSPTSPTATSTTP CCCCCCCCCCCCCCC | 28.64 | 16262601 | |
| 95 | Phosphorylation | SPSPTSPTATSTTPS CCCCCCCCCCCCCCH | 42.19 | 29255136 | |
| 96 | Phosphorylation | PSPTSPTATSTTPSR CCCCCCCCCCCCCHH | 11.70 | - | |
| 97 | Phosphorylation | SPTSPTATSTTPSRY CCCCCCCCCCCCHHH | 29.14 | 29255136 | |
| 98 | Phosphorylation | PTSPTATSTTPSRYK CCCCCCCCCCCHHHH | 28.02 | 30108239 | |
| 99 | Phosphorylation | TSPTATSTTPSRYKT CCCCCCCCCCHHHHH | 38.07 | 30576142 | |
| 100 | Phosphorylation | SPTATSTTPSRYKTE CCCCCCCCCHHHHHH | 21.02 | 30108239 | |
| 101 | Phosphorylation | PTATSTTPSRYKTEL CCCCCCCCHHHHHHH | 19.52 | - | |
| 102 | Phosphorylation | TATSTTPSRYKTELC CCCCCCCHHHHHHHE | 46.26 | 30108239 | |
| 105 | Acetylation | STTPSRYKTELCRTF CCCCHHHHHHHEECC | 34.12 | 27452117 | |
| 105 | Phosphorylation | STTPSRYKTELCRTF CCCCHHHHHHHEECC | 34.12 | - | |
| 105 | Ubiquitination | STTPSRYKTELCRTF CCCCHHHHHHHEECC | 34.12 | - | |
| 106 | Phosphorylation | TTPSRYKTELCRTFS CCCHHHHHHHEECCC | 25.84 | 16262601 | |
| 111 | Phosphorylation | YKTELCRTFSESGRC HHHHHEECCCCCCCC | 30.43 | 16262601 | |
| 111 | Ubiquitination | YKTELCRTFSESGRC HHHHHEECCCCCCCC | 30.43 | - | |
| 112 | Phosphorylation | KTELCRTFSESGRCR HHHHEECCCCCCCCC | 3.84 | - | |
| 113 | Phosphorylation | TELCRTFSESGRCRY HHHEECCCCCCCCCH | 30.18 | 24670416 | |
| 115 | Phosphorylation | LCRTFSESGRCRYGA HEECCCCCCCCCHHC | 30.27 | 26699800 | |
| 117 | Phosphorylation | RTFSESGRCRYGAKC ECCCCCCCCCHHCCC | 15.83 | - | |
| 119 | Phosphorylation | FSESGRCRYGAKCQF CCCCCCCCHHCCCHH | 31.40 | - | |
| 120 | Phosphorylation | SESGRCRYGAKCQFA CCCCCCCHHCCCHHH | 25.68 | - | |
| 123 | Ubiquitination | GRCRYGAKCQFAHGL CCCCHHCCCHHHCHH | 24.98 | - | |
| 129 | Ubiquitination | AKCQFAHGLGELRQA CCCHHHCHHHHHHHH | 31.76 | - | |
| 149 | Ubiquitination | YKTELCHKFYLQGRC CCHHHCHHHHCCCCC | 34.41 | - | |
| 158 | Phosphorylation | YLQGRCPYGSRCHFI HCCCCCCCCCCCEEE | 31.21 | 16262601 | |
| 160 | Phosphorylation | QGRCPYGSRCHFIHN CCCCCCCCCCEEECC | 26.37 | 16262601 | |
| 164 | Phosphorylation | PYGSRCHFIHNPSED CCCCCCEEECCCCHH | 7.51 | - | |
| 166 | Phosphorylation | GSRCHFIHNPSEDLA CCCCEEECCCCHHCC | 38.92 | - | |
| 169 | Phosphorylation | CHFIHNPSEDLAAPG CEEECCCCHHCCCCC | 49.40 | 16262601 | |
| 175 | Phosphorylation | PSEDLAAPGHPPVLR CCHHCCCCCCCCCCC | 35.70 | 16262601 | |
| 184 | Phosphorylation | HPPVLRQSISFSGLP CCCCCCEEECCCCCC | 17.48 | 30266825 | |
| 186 | Phosphorylation | PVLRQSISFSGLPSG CCCCEEECCCCCCCC | 20.71 | 23401153 | |
| 188 | Phosphorylation | LRQSISFSGLPSGRR CCEEECCCCCCCCCC | 32.41 | 30266825 | |
| 190 | Phosphorylation | QSISFSGLPSGRRTS EEECCCCCCCCCCCC | 2.71 | - | |
| 192 | Phosphorylation | ISFSGLPSGRRTSPP ECCCCCCCCCCCCCC | 50.39 | 23927012 | |
| 194 | Phosphorylation | FSGLPSGRRTSPPPP CCCCCCCCCCCCCCC | 42.94 | - | |
| 196 | Phosphorylation | GLPSGRRTSPPPPGL CCCCCCCCCCCCCCC | 44.20 | 16262601 | |
| 197 | Phosphorylation | LPSGRRTSPPPPGLA CCCCCCCCCCCCCCC | 33.33 | 16262601 | |
| 202 | Phosphorylation | RTSPPPPGLAGPSLS CCCCCCCCCCCCCCC | 33.65 | - | |
| 203 | Phosphorylation | TSPPPPGLAGPSLSS CCCCCCCCCCCCCCC | 6.50 | 16262601 | |
| 207 | Phosphorylation | PPGLAGPSLSSSSFS CCCCCCCCCCCCCCC | 39.71 | 16262601 | |
| 209 | Phosphorylation | GLAGPSLSSSSFSPS CCCCCCCCCCCCCCC | 32.29 | 27251275 | |
| 210 | Phosphorylation | LAGPSLSSSSFSPSS CCCCCCCCCCCCCCC | 34.98 | 16262601 | |
| 211 | Phosphorylation | AGPSLSSSSFSPSSS CCCCCCCCCCCCCCC | 31.84 | 27251275 | |
| 212 | Phosphorylation | GPSLSSSSFSPSSSP CCCCCCCCCCCCCCC | 31.52 | 27251275 | |
| 213 | Phosphorylation | PSLSSSSFSPSSSPP CCCCCCCCCCCCCCC | 15.64 | - | |
| 214 | Phosphorylation | SLSSSSFSPSSSPPP CCCCCCCCCCCCCCC | 26.31 | 23909892 | |
| 216 | Phosphorylation | SSSSFSPSSSPPPPG CCCCCCCCCCCCCCC | 42.10 | 27251275 | |
| 217 | Phosphorylation | SSSFSPSSSPPPPGD CCCCCCCCCCCCCCC | 50.69 | 16262601 | |
| 218 | Phosphorylation | SSFSPSSSPPPPGDL CCCCCCCCCCCCCCC | 45.85 | 16262601 | |
| 220 | Phosphorylation | FSPSSSPPPPGDLPL CCCCCCCCCCCCCCC | 50.06 | - | |
| 223 | Phosphorylation | SSSPPPPGDLPLSPS CCCCCCCCCCCCCHH | 55.66 | - | |
| 224 | Phosphorylation | SSPPPPGDLPLSPSA CCCCCCCCCCCCHHH | 51.38 | 16262601 | |
| 228 | Phosphorylation | PPGDLPLSPSAFSAA CCCCCCCCHHHHCCC | 18.18 | 7768935 | |
| 230 | Phosphorylation | GDLPLSPSAFSAAPG CCCCCCHHHHCCCCC | 38.27 | 16262601 | |
| 233 | Phosphorylation | PLSPSAFSAAPGTPL CCCHHHHCCCCCCCC | 24.20 | 16262601 | |
| 234 | Phosphorylation | LSPSAFSAAPGTPLA CCHHHHCCCCCCCCC | 15.95 | 16262601 | |
| 236 | Phosphorylation | PSAFSAAPGTPLARR HHHHCCCCCCCCCCC | 47.08 | - | |
| 238 | Phosphorylation | AFSAAPGTPLARRDP HHCCCCCCCCCCCCC | 17.67 | 16262601 | |
| 239 | Phosphorylation | FSAAPGTPLARRDPT HCCCCCCCCCCCCCC | 29.91 | - | |
| 244 | Phosphorylation | GTPLARRDPTPVCCP CCCCCCCCCCCCCCC | 45.96 | - | |
| 252 | Phosphorylation | PTPVCCPSCRRATPI CCCCCCCCCCCCCCE | 13.31 | 16262601 | |
| 257 | Phosphorylation | CPSCRRATPISVWGP CCCCCCCCCEEEEEC | 21.24 | 21815630 | |
| 258 | Phosphorylation | PSCRRATPISVWGPL CCCCCCCCEEEEECC | 18.84 | - | |
| 260 | Phosphorylation | CRRATPISVWGPLGG CCCCCCEEEEECCCC | 17.02 | 28450419 | |
| 263 | Phosphorylation | ATPISVWGPLGGLVR CCCEEEEECCCCCEE | 12.85 | - | |
| 271 | Phosphorylation | PLGGLVRTPSVQSLG CCCCCEECCCHHHCC | 16.67 | 16262601 | |
| 273 | Phosphorylation | GGLVRTPSVQSLGSD CCCEECCCHHHCCCC | 31.98 | 16262601 | |
| 276 | Phosphorylation | VRTPSVQSLGSDPDE EECCCHHHCCCCHHH | 32.32 | 16262601 | |
| 277 | Phosphorylation | RTPSVQSLGSDPDEY ECCCHHHCCCCHHHH | 4.21 | - | |
| 279 | Phosphorylation | PSVQSLGSDPDEYAS CCHHHCCCCHHHHHH | 51.79 | 16262601 | |
| 282 | Phosphorylation | QSLGSDPDEYASSGS HHCCCCHHHHHHCCC | 67.54 | 16262601 | |
| 284 | Phosphorylation | LGSDPDEYASSGSSL CCCCHHHHHHCCCCC | 21.11 | 16262601 | |
| 285 | Phosphorylation | GSDPDEYASSGSSLG CCCHHHHHHCCCCCC | 8.65 | - | |
| 290 | Phosphorylation | EYASSGSSLGGSDSP HHHHCCCCCCCCCCC | 34.26 | - | |
| 294 | Phosphorylation | SGSSLGGSDSPVFEA CCCCCCCCCCCCEEC | 32.87 | 16262601 | |
| 296 | Phosphorylation | SSLGGSDSPVFEAGV CCCCCCCCCCEECCC | 25.35 | 16262601 | |
| 300 | Phosphorylation | GSDSPVFEAGVFAPP CCCCCCEECCCCCCC | 44.76 | - | |
| 302 | Phosphorylation | DSPVFEAGVFAPPQP CCCCEECCCCCCCCC | 14.10 | 16262601 | |
| 323 | Phosphorylation | LPIFNRISVSE---- CCCCCCCCCCC---- | 19.16 | 23644599 | |
| 325 | Phosphorylation | IFNRISVSE------ CCCCCCCCC------ | 30.69 | 23090842 | |
| 329 | Phosphorylation | ISVSE---------- CCCCC---------- | - | ||
| 331 | Phosphorylation | VSE------------ CCC------------ | - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TTP_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND MASSSPECTROMETRY. | |
| "MK2-induced tristetraprolin:14-3-3 complexes prevent stress granuleassociation and ARE-mRNA decay."; Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F.,Blackwell T.K., Anderson P.; EMBO J. 23:1313-1324(2004). Cited for: PHOSPHORYLATION AT SER-60 AND SER-186 BY MAPKAPK2, SUBCELLULARLOCATION, RNA-BINDING, FUNCTION, AND MUTAGENESIS OF SER-60 ANDSER-186. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-92, AND MASSSPECTROMETRY. | |